Participants 146 194 3
patients with chronic idiopathic urticaria (CIU)
Participants 422 464 3
AH-resistant and AH responder CIU patients
Participants 466 535 3
CIU patients with treatment failure under fexofenadine at 180 mg q.d.
Participants 849 932 6
The control group consisted of sex- and age-matched patents with allergic rhinitis.
Participants 1093 1205 6
Forty-six subjects were included in the CIU group, 21 were in the R-CIU group, and 44 were in the control group.
